| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.095 | 0.05 |
| mRNA | LAQ824 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.05 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | 0.13 | 0.05 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.06 | 0.05 |
| mRNA | KU-0063794 | CTRPv2 | pan-cancer | AAC | 0.072 | 0.05 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.05 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.06 |